Simplify Logo

Full-Time

Vice President

Corporate Controller

Confirmed live in the last 24 hours

Freenome

Freenome

501-1,000 employees

Biotechnology company for early cancer detection

Biotechnology
Healthcare

Compensation Overview

$253.7k - $401.5kAnnually

+ Pre-IPO Equity + Cash Bonuses

Senior, Expert

Daly City, CA, USA

Category
Financial Accounting
Financial Controller
Management Accounting
Accounting
Required Skills
NetSuite
Data Analysis
Requirements
  • Bachelor's degree in accounting or a related field (advanced degree preferred)
  • Strong technical accounting skills and proficiency in implementation of U.S. GAAP, Sarbanes-Oxley, and SEC regulations
  • Minimum of 15+ years of relevant experience
  • Extensive experience in controllership roles in publicly traded life sciences company (minimum 6 years)
  • Biotechnology/pharmaceutical/diagnostic industry experience required; experience building out accounting operations for a commercial organization are highly desirable (diagnostics industry)
  • Must have strong experience implementing and managing a global legal entity structure in NetSuite
  • Excellent communication and interpersonal skills, with the ability to effectively collaborate with cross-functional teams, Freenome’s leadership, and external stakeholders
  • High degree of integrity, ethics and professionalism, with a commitment to uphold the highest standards
  • Proven leadership and team building skills, with the ability to motivate others towards achieving common goals
  • Proven ability to evaluate existing talent and implement necessary changes in order to scale the accounting organization to meet public company accounting close and reporting timelines
  • Proven ability to meet tight timelines and manage competing priorities in a dynamic environment
Responsibilities
  • Hands-on management of accounting close process with focused effort to continuously drive efficiencies in order to enable an accurate 6-day accounting close
  • Evaluate and initiate actions to build, develop, motivate, lead, unite and align accounting team capable of exceeding performance expectations
  • Review and approve journal entries and account reconciliations as appropriate; enhance documentation and evidence of review over journal entries and account reconciliations to meet SOX compliance requirements
  • Implement balance sheet, income statement, and cash flow analytics as part of the accounting close process to support internal management reporting
  • Implement processes to identify and review accounting implications of non-standard contracts and agreements to ensure that appropriate technical accounting matters are documented and implemented in the Company’s accounting records
  • Lead and drive the implementation/upgrade of various systems and leverage technology to build scalable/sustainable processes to create efficiencies in the accounting close and reporting processes (e.g., leverage power of NetSuite to build out reporting capabilities)
  • Prepare and/or review schedules to support the preparation of external financial statements, footnotes, and MD&A (e.g., 10-Q, 10-K, S-1)
  • Prepare and present materials at board and related committee meetings (e.g., audit committee); manage audit committee charter to ensure all mandated audit committee actions are addressed
  • Develop and implement best-in-class procure to pay processes; evaluate, provide recommendations and update financial approval matrix and workflows
  • Support the implementation of a Contract Lifecycle Management System
  • Oversee compliance with Travel & Entertainment (T&E) Policy and corporate credit card program; evaluate current T&E expense management reporting software and propose/implement alternative solutions
  • Oversee treasury process and external tax service providers
  • Collaborate closely with Director, SEC Reporting/SOX Compliance to ensure appropriate controls over financial processes are designed and operating effectively
  • Responsible for maintaining strong internal controls and ensuring accounting team is effectively trained
  • Coordinate quarterly reviews and annual audits with external auditors; ensure that all PBCs are prepared accurately and provided timely to support an efficient and unqualified audit; support internal audits and SOX audits as required
  • Stay updated on relevant accounting standards and regulatory changes impacting the biotech/diagnostic industry
  • Maintain state of IPO readiness, including operating under public company accounting close and reporting timelines, facilitating external auditor quarterly reviews, providing supporting schedules to Director SEC Reporting/SOX
  • Compliance for preparation of quarterly footnotes and MD&A
  • Support due diligence efforts and interface with external stakeholders, including underwriters and legal counsel in connection with potential IPO diligence
  • Provide leadership and guidance to the accounting team, fostering a culture of excellence and continuous improvement
  • Promote professional development and skill enhancement initiatives to build a high-performing accounting organization
  • Collaborate cross-functionally with other departments to drive financial literacy and accountability throughout the organization

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations, which enhance the reliability of its tests. The goal of Freenome is to provide healthcare providers and research institutions with accurate diagnostic tools that can lead to earlier cancer detection, ultimately improving patient outcomes.

Company Stage

Series D

Total Funding

$1.1B

Headquarters

San Francisco, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Freenome's recent $254 million funding round will accelerate its platform capabilities and expand clinical trials, offering significant growth opportunities.
  • The initiation of the PROACT LUNG study for early lung cancer detection highlights Freenome's commitment to expanding its diagnostic capabilities beyond colorectal cancer.
  • Partnerships with major entities like Walgreens enhance Freenome's reach and credibility in the healthcare sector.

What critics are saying

  • The recent layoff of 100 employees could indicate financial instability or strategic misalignment, affecting employee morale.
  • The highly competitive landscape of cancer diagnostics requires continuous innovation to maintain a leading position.

What makes Freenome unique

  • Freenome's unique multiomics approach, combining genomics and proteomics, sets it apart from competitors who may focus on single data types.
  • The company's significant funding, including a recent $270 million investment, underscores strong investor confidence and provides a financial edge over less-funded competitors.
  • Freenome's collaborative culture and commitment to diversity, equity, and inclusion foster a unique work environment that attracts top talent.

Benefits

Competitive market-based salaries

Annual bonus opportunities

Relocation packages

Medical, dental, & vision coverage

401k

Wellness programs

Equity

PTO